Literature DB >> 18497562

Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.

Jason Yongsheng Chan1, Meng Seng Phoo, Marie-Veronique Clement, Shazib Pervaiz, Shao Chin Lee.   

Abstract

We have reported that resveratrol (RSV) evoked apoptosis through caspase-6 activation in HCT116 human colon cancer cells wild-type (p53+/+) or knockout (p53-/-) for p53. In this study, the role of caspase-6 activation in 5-fluorouracil (5-FU)-elicited apoptosis as well as the combination effects between RSV and 5-FU on their apoptosis induction was further investigated in the same colon cancer cell model. The combination effects were determined by calculation of combination indices (CI). We found that 5-FU triggered apoptosis and caspase-6 activation in the cancer cells, which were entirely abrogated by caspase-6 inhibitors. RSV (200 microM) increased 5-FU-triggered apoptosis and caspase-6 activation. Lower doses (25 or 50 microM) inhibited 5-FU-mediated apoptosis and caspase-6 activation only in p53+/+ cells. Moreover, G(1)-arrest of the p53+/+ cells was elicited by lower doses of RSV and 5-FU in combination, but not with either agent alone. RSV (200 microM) interacted with 5-FU in a synergistic manner (mean CI < 0.9). At lower doses (25 or 50 microM), it interacted with 5-FU in antagonistic (mean CI > 1.1) and additive manners (0.9 < mean CI < 1.1) in p53+/+ and p53-/- cells respectively. In conclusion, our results suggest that, like RSV, 5-FU triggers the cancer cell apoptosis by activating caspase-6. Their combination effect in apoptosis induction is dependent on the concentration of RSV and is mediated by caspase-6 activation. RSV synergistically promotes 5-FU-mediated apoptosis at its higher concentration irrespective of p53. Conversely, it inhibits 5-FU-triggered apoptosis at lower concentrations in p53+/+ cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497562     DOI: 10.4161/cbt.7.8.6302

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

1.  A tumor vessel-targeting fusion protein elicits a chemotherapeutic bystander effect in pancreatic ductal adenocarcinoma.

Authors:  Chun-Te Chen; Yi-Chun Chen; Yi Du; Zhenbo Han; Haoqiang Ying; Richard R Bouchard; Jennifer L Hsu; Jung-Mao Hsu; Trevor M Mitcham; Mei-Kuang Chen; Hui-Lung Sun; Shih-Shin Chang; Donghui Li; Ping Chang; Ronald A DePinho; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes.

Authors:  Jacqueline Brown; Hannelie Bothma; Robin Veale; Pascale Willem
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 3.  Chemosensitization of tumors by resveratrol.

Authors:  Subash C Gupta; Ramaswamy Kannappan; Simone Reuter; Ji Hye Kim; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

4.  Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.

Authors:  Jürgen Sonnemann; Melanie Kahl; Priyanka M Siranjeevi; Annelie Blumrich; Lisa Blümel; Sabine Becker; Susan Wittig; René Winkler; Oliver H Krämer; James F Beck
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-09       Impact factor: 4.553

Review 5.  Drug-herb combination therapy in cancer management.

Authors:  Urvashi Langeh; Vishal Kumar; Charan Singh; Arti Singh
Journal:  Mol Biol Rep       Date:  2022-09-09       Impact factor: 2.742

6.  The role of nutraceuticals in chemoprevention and chemotherapy and their clinical outcomes.

Authors:  Sabita N Saldanha; Trygve O Tollefsbol
Journal:  J Oncol       Date:  2011-12-07       Impact factor: 4.375

7.  By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.

Authors:  Weiqi Dai; Fan Wang; Jie Lu; Yujing Xia; Lei He; Kan Chen; Jingjing Li; Sainan Li; Tong Liu; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Yuqing Zhou; Qin Yin; Huerxidan Abudumijiti; Rongxia Chen; Rong Zhang; Li Zhou; Zheng Zhou; Rong Zhu; Jing Yang; Chengfen Wang; Huawei Zhang; Yingqun Zhou; Ling Xu; Chuanyong Guo
Journal:  Oncotarget       Date:  2015-05-30

8.  The 15kDa selenoprotein and thioredoxin reductase 1 promote colon cancer by different pathways.

Authors:  Petra A Tsuji; Bradley A Carlson; Min-Hyuk Yoo; Salvador Naranjo-Suarez; Xue-Ming Xu; Yiwen He; Esther Asaki; Harold E Seifried; William C Reinhold; Cindy D Davis; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

9.  Synergistic Interaction between 5-FU and an Analog of Sulforaphane-2-Oxohexyl Isothiocyanate-In an In Vitro Colon Cancer Model.

Authors:  Małgorzata Milczarek; Anna Pogorzelska; Katarzyna Wiktorska
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

10.  Expression and activation of caspase-6 in human fetal and adult tissues.

Authors:  Nelly Godefroy; Bénédicte Foveau; Steffen Albrecht; Cynthia G Goodyer; Andréa C LeBlanc
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.